Par Technology Q2 FY26 adjusted EBITDA more than doubled to $14.3 million; revenue rises 18.7% to $133.4 million
Reuters2026/08/06 20:23- Par Technology posted Q2 2026 revenue of $133.4 million, up 18.7% year-over-year.
- GAAP net loss narrowed to $16.9 million; GAAP diluted loss per share improved to $0.41.
- Non-GAAP adjusted EBITDA rose to $14.3 million from $5.5 million a year earlier.
- ARR climbed 17% year-over-year to $338 million; active sites totaled 174,300 at June 30.
- Raised full-year 2026 outlook to revenue of $516 million-$523 million; lifted adjusted EBITDA view to $50 million-$53 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Fogo Foundation Attacked, Approximately 400 Million FOGO Tokens Transferred
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)
A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.
Crypto prices
More
